Poniard Pharmaceuticals Inc PARD:OTCPK

RT Quote | Exchange | USD
Last | 02/22/21 EST
0.066UNCH (UNCH)
Volume
87
52 week range
0.03 - 0.12

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.066
  • 52 Week High0.12
  • 52 Week High Date02/11/21
  • 52 Week Low0.03
  • 52 Week Low Date03/19/20
  • Market Cap100,000.00
  • Shares Out1.50M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • 1 Year % Change10

RATIOS/PROFITABILITY

  • EPS (TTM)-11.92
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-13.041M
  • ROE (MRQ)-212.95%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)52.61%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Poniard Pharmaceuticals Inc News

There is no recent news for this security.

Latest PARD News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Ronald Martell
Chairman
Address
750 Battery St Ste 330
San Francisco, CA
94111-1525
United States